02282nas a2200217 4500000000100000008004100001100002000042700001800062700001900080700001700099700001600116700002600132700001500158700002300173700001800196700001800214700002200232245015300254520164300407022001402050 2018 d1 aOhkuma Toshiaki1 aKomorita Yuji1 aIwase Masanori1 aFujii Hiroki1 aIde Hitoshi1 aJodai-Kitamura Tamaki1 aSumi Akiko1 aYoshinari Masahito1 aNakamura Udai1 aKang Dongchon1 aKitazono Takanari00aImpact of Body Weight Loss From Maximum Weight on Fragility Bone Fractures in Japanese Patients With type 2 Diabetes: the Fukuoka Diabetes Registry.3 a

OBJECTIVE: There is growing evidence that weight loss is associated with increased fracture risk in the general population. As patients with diabetes often lose weight intentionally or unintentionally, we aimed to investigate prospectively the relationship between weight loss from maximum body weight and fracture risk.

RESEARCH DESIGN AND METHODS: A total of 4,706 Japanese participants with type 2 diabetes (mean age 66 years), including 2,755 men and 1,951 postmenopausal women, were followed for a median of 5.3 years and were divided according to weight loss from maximum weight: <10%, 10% to <20%, 20% to <30%, and ≥30%. The primary outcomes were fragility fractures defined as fractures at sites of hip and spine.

RESULTS: During the follow-up period, fragility fractures occurred in 198 participants. The age- and sex-adjusted incidence rates per 1,000 person-years in all participants were 6.4 (<10% weight loss from maximum body weight), 7.8 (10% to <20%), 11.7 (20% to <30%), and 19.2 (≥30%) (for trend <0.001). Multivariate-adjusted hazard ratios for fragility fractures compared with reference (<10% weight loss) were 1.48 ([95% CI] 0.79-2.77) in the 10% to <20% group, 2.23 (1.08-4.64) in 20% to <30%, and 5.20 (2.15-12.57) in ≥30% in men, and 1.19 (0.78-1.82) in 10% to <20%, 1.62 (0.96-2.73) in 20% to <30%, and 1.97 (0.84-4.62) in ≥30% in postmenopausal women.

CONCLUSIONS: The current study demonstrates that ≥20% body weight loss from maximum weight is a significant risk factor for fragility fractures in patients with type 2 diabetes, especially in men.

 a1935-5548